The Measure-ASD Study assesses changes in key developmental milestones over time, such as a child’s verbal ability, non-verbal learning, and social disability. By studying these early milestones in both typically developing children and children with autism or related vulnerabilities, researchers hope to identify changes in an individual child’s developmental status over time, such as improvement or no improvement, in the core dimensions of autism. The study also seeks to measure how much change happens from month to month, if change occurs.
The study uses the EarliPoint™ system, a novel FDA-authorized device that measures a child’s individual attention to social situations at a rate that is undetectable to the human eye. Qualified participants will receive free developmental assessments and study-related compensation.
STATE | CITY | CENTER |
Arizona | Phoenix | |
California |
Glendale San Rafael Torrance Westlake Village |
|
Georgia | Atlanta | |
Ohio | Cincinnati | |
Nebraska | Omaha |
Munroe-Meyer Institute |
Pennsylvania | Philadelphia |
Eligible children and their parents or caregivers will visit a designated research center once per month for six months to undergo assessments by researchers who specialize in the diagnosis and treatment of autism. During these visits, children will watch videos of various social scenes, like children playing, while the EarliPoint™ device measures their looking behavior.
At three of the visits, the researchers will also perform standard developmental assessments, which measure key developmental milestones such as verbal ability, non-verbal learning, and social communication, to determine if change is occurring over time.
Visits are expected to last approximately 1–4.5 hours from start to finish, depending on which assessments are being performed at the visit.
Seven Visits at a Designated Research Site
Clinical trials need volunteers like you to research potential breakthroughs. By participating, you are helping to advance our understanding of key developmental milestones and when important changes occurs over time. If you are interested in…
… please see if you qualify.
If you qualify, a study coordinator from the closest study site will contact you within 5 business days to provide additional details.
Thank you! You are helping to make earlier identification and treatment of autism accessible to children everywhere!
No. This is a free and confidential study. You will also receive developmental assessments at no cost.
Qualified participants may receive study-related compensation, such as mileage reimbursement to attend the study visits.
Yes. Your participation is voluntary, and you may withdraw for any reason. If you withdraw prior to completing the study, you will be asked to notify the study team before doing so and to complete a final visit.
Your privacy is important to us. Measure-ASD is a confidential study. The Informed Consent (completed prior to enrolling) provides detail about maintaining your privacy. In general, data collected is appended to a numeric code that will not identify your child. Data collected is only available to study-related personnel and is subject to health information privacy regulations.